» Articles » PMID: 39816166

Characterization and Enhanced Antibiofilm Activity of Extract in Combination with Fluconazole Against

Overview
Date 2025 Jan 16
PMID 39816166
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: biofilm formation is a significant contributor to antifungal resistance, necessitating new treatment strategies. Lin., a traditional herbal remedy, has shown promise in combating microbial infections. The purpose of this study was to assess the antibiofilm activity of the methanol extract of leaves alone or with the addition of fluconazole against .

Methods: Phytochemicals from the methanol extract were analyzed by LC-MS, the XTT assay was used for metabolic activity, and morphological characteristics were examined using scanning electron microscopy (SEM). Molecular docking screening of identified compounds in methanol leaves extract against a Sap3 receptor (PDB: 2H6T) was also performed.

Results: The LC-MS analysis detected 17 possible phytochemicals. The methanol extract showed a dose-dependent inhibition of biofilm formation, with maximum inhibition of ~60% observed at 240 μg/ml, and inhibition by fluconazole increased from 32% to 76% as the concentration increased from 15 to 240 μg/ml. The combination of and fluconazole increased the inhibition significantly, from 74% to 78% at 15 μg/ml to 240 μg/mL, respectively. SEM of control and treated biofilms showed an altered morphology and loss of cell integrity by the combination, corroborating the findings. Plant phytochemicals also possess high binding affinity (-9.7 to 8.0 kcal/mol, respectively) for the Sap3 enzyme and may therefore have therapeutic potential against .

Conclusion: Consequently, the findings indicate that compounds in the methanol extract may function in concert with fluconazole at sub-inhibitory concentrations to suppress biofilm formation. This finding paves the way for the formulation and development of antifungal treatment regimens that may limit the development of fluconazole resistance employing this plant part.

References
1.
Ahmed A, McGaw L, Elgorashi E, Naidoo V, Eloff J . Polarity of extracts and fractions of four Combretum (Combretaceae) species used to treat infections and gastrointestinal disorders in southern African traditional medicine has a major effect on different relevant in vitro activities. J Ethnopharmacol. 2014; 154(2):339-50. DOI: 10.1016/j.jep.2014.03.030. View

2.
George V, Naveen Kumar D, Rajkumar V, Suresh P, Ashok Kumar R . Quantitative assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. in normal and immortalized human cell lines. Asian Pac J Cancer Prev. 2012; 13(2):699-704. DOI: 10.7314/apjcp.2012.13.2.699. View

3.
Gu Z, Zhou D, Wu J, Shi G, Zeng L, McLaughlin J . Screening for Annonaceous acetogenins in bioactive plant extracts by liquid chromatography/mass spectrometry. J Nat Prod. 1997; 60(3):242-8. DOI: 10.1021/np960487i. View

4.
Matsushige A, Kotake Y, Matsunami K, Otsuka H, Ohta S, Takeda Y . Annonamine, a new aporphine alkaloid from the leaves of Annona muricata. Chem Pharm Bull (Tokyo). 2012; 60(2):257-9. DOI: 10.1248/cpb.60.257. View

5.
Ferraz C, Silva D, Silva Prado L, Canabrava H, Bispo-da-Silva L . Antidiarrhoeic effect and dereplication of the aqueous extract of Annona crassiflora (Annonaceae). Nat Prod Res. 2017; 33(4):563-567. DOI: 10.1080/14786419.2017.1396589. View